Abiopharma

🔍 Daniels Lisa Lynn (Director)

Company: CAVCO INDUSTRIES, INC. (CVCO)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Sold 30 shares of Common Stock at $569.96 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 297.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025, and does not represent a discretionary transaction. This plan was adopted in order to sell-to-cover 30 shares to satisfy income tax obligations incurred by the Reporting Person in connection with the vesting of their restricted stock units on July 28, 2026. The Reporting Person's Rule 10b5-1 trading plan has no remaining shares available to be sold and is terminated.
• F2: Includes 225 shares underlying Restricted Stock Units allocated but not yet vested or delivered.